Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids for Prevention of Stenosis After Caustic Ingestion
NCT03760354Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, double-blind trial in caustic esophageal injury comparing Methylprednisolone with Placebo (2 arms). Primary endpoint: Indication for esophageal or pharyngeal surgical reconstruction at 12 months. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
caustic esophageal injury
Beyond the preview
Go deeper on NCT03760354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03760354.